Sildenafil Citrate
Product Images NDC 17856-8100

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 17856-8100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (17856 8100 01)

This is a medication package of Sildenafil with 20 mg strength. Each package contains 1 tablet and the total quantity is 200 sachets. It is recommended to store the medication at room temperature and keep it out of reach of children. The medication is manufactured by Rubicon Research PVT. However, the package insert should be consulted for dosage and indications schedule.*

FDA Label Image

Image 2 (17856 8100 02)

This is a description of a medication called Sildenafil in 20mg dosage, consisting of 2 tablets per package. The package insert provides information on indications and dosage schedules. The medication should be stored within a temperature range of 20°C to 25°C and kept out of reach of children. The GTIN for the package is 0017856810025 along with other details such as expiry date, lot number, and manufacturer. The medication is packed by Unit Dose Solutions and manufactured by Rubicon Research Pvt.*

FDA Label Image

Image 3 (17856 8100 03)

This is a medication package for Sildenafil 20 mg containing 3 tablets. It includes instructions on storage, dosage and a reference to a package insert for more detailed information.*

FDA Label Image

Image 4 (17856 8100 04)

This is a medication package containing 4 tablets of Sildenafil 20mg. The package has a revision date of January 2019 and refers the user to the package insert for dosage and indications. The user is advised to store the medication at a controlled room temperature and out of reach of children. The last line of text is not readable.*

FDA Label Image

Image 5 (17856 8100 05)

This is a description of Sildenafil tablets containing 20mg of the active ingredient. The package contains 5 tablets with dosage instructions provided in the package insert. The medication should be stored between 20-25°C and kept out of reach of children. The GTIN code is provided for identification purposes. The lot number and expiration date are also noted on the package.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 06)

Not available.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 07)

This is a chart or table displaying recommendations for dose adjustments for certain drugs when used in combination with another drug, mainly based on the AUC and Cmax values. It mentions drugs such as Acitomycin, Bosentan, Cimetidines, Evomyeint, Maslox, OralContraceptives, Rionavit, and Sapionis. The chart shows the fold change and 90% confidence interval recommendation, as well as the nodose adjustment for these drugs. There is also a reference to Sienafil and its impact on exercise capacity when added to bosentan therapy.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 08)

This is a drug interaction table that shows potential interaction effects between Acenocoumarol and other drugs. The table shows Fold Change and 90% CI Recommendation for various drugs regarding their interaction with Acenocoumarol. The recommendation mostly suggests "no dose adjustment" for most drugs except for a few where co-administration is not recommended. The table also includes a note about ritonavir's effect on sildenafil PK, suggesting not using it. The text mentions the BT (bleeding time) effect of aspirin and the lack of exercise capacity benefit when sildenafil is added to bosentan therapy.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 09)

The text represents a table with measurements expressed in meters. The measurements were taken at different time intervals, specifically at Week 4, Week 8, and Week 12 of a study. There were four treatment groups as indicated by the key at the bottom. The first group received a placebo, the second group received 20mg of Sildenafil taken three times per day (TID), the third group received 40mg of Sildenafil TID, and the fourth group received 80mg of Sildenafil TID. The meaning of the numbers in the table is not clear, but they likely represent changes in some parameter from baseline for each treatment group.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 10)

This is a medical study on Idiopathic Pulmonary Arterial Hypertension. The patients were given Placebo or Sildenafil 20 mg. Information on their Baseline walk distance, age, gender, and Mean PAP levels were recorded. The study also measured Placabo-corrected Change in 6-Minute Walk Distance (m).*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 11)

Not available.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 12)

FDA Label Image

Structure Formula (Sildenafil Tablets Usp 20mg Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.